🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Proud & grateful -> Stockholm men creating evidence on improved tools -> PCa #screening. Step on implementation road. Karolinska Institutet Sigrid Carlsson Matt Cooperberg Hein Van Poppel

Best abstracts in prostate cancer #EAU21

Dr Martin Eklund Karolinska Institutet speaks to ecancer about his #EAU21 prize-winning STHLM3MRI presentation and how MRI screening and targeted biopsies could cut overdiagnoses of #prostatecancer. Watch here👉bit.ly/3hPmqTK

New Platinum Priority – Prostate Cancer from Andrew Vickers Effects of Magnetic Resonance Imaging Targeting on Overdiagnosis and Overtreatment of Prostate Cancer buff.ly/2UTSsoG

Is systematic biopsies in MRI-positive men the new pathway? Keeps the upside of MRI (spare men from bx, less GG1) and syst bx (less overestimated tumor burden)

Are you interested in the meaning of this landmark paper in prostate cancer screening? Are you wondering whether it should change practice? To find out read this tweetorial: nejm.org/doi/full/10.10…. #UroSoME #pcsm Stacy Loeb, MD Declan Murphy Juan Gómez Rivas Dr. Zainal Adwin 🇲🇾 🌺 (1/16)

A novel blood test can reduce the number of #prostatecancer MRIs performed by a third while further preventing the detection of minor, low-risk tumours. New study in The Lancet Oncology by KI researchers Tobias Nordström, Martin Eklund, et al. @Danderydssjukh bit.ly/37GgdDI

Combination of blood-based risk prediction and MRI way forward to shift benefit-harm balance in #prostatecancer #screening. Proud to share results, grateful to participants and funders. #sthlm3 Cancerfonden

MRI with targeted biopsy might improve diagnostic accuracy in prostate cancer screening. New research findings are summarized. nej.md/3y879lT

⁦now #eau22: Tobias Nordström⁩ reviews truly exceptional success to date of the STHML3 #prostatecancer screening program

Grateful for an exceptional in-person #EAU22 weekend with many uro-friends! Excited to see prostate cancer detection moving ⏩. Humble to receive EAU Prostate Cancer Reseach Award 2022! Now slow stroll through Schiphol… Sigrid Carlsson Monique Roobol Matt Cooperberg

MRI-based screening reduced the number of both lifetime biopsies and overdiagnosis by approximately 50% and had a high probability of being cost-effective than the traditional PSA screening. From JAMA jamanetwork.com/journals/jamao…

Excellent updates on PROBASE (Kathleen Herkommer) SHTML3-MRI (Tobias Nordström) as well. Running circles around the US in terms of actually testing innovative screening strategies for #prostatecancer! #EAU23

Guess this is key slide from Freddie's talk. It's given me a bit of an existential crisis over past 36hrs Should we approach all localised #ProstateCancer like we now do salvageRT? i.e. put EVERYONE on surveillance, then only treat those who 'progress'?? (1/3 were T3!) #EAU23

In Paris, a new “Everything Is Fine” gif is born x.com/marjo_beb/stat…

Repeat PC screen w PSA+MRI at 2-3 yrs-> many negative MRIs & limited ca detection. Improved risk prediction & de-escalation for low risk men way forward?

Editor's Choice of the Week: The Highest Grade Group Does Not Drive the Risk of Recurrence when Systematic and MRI-targeted Biopsies are Discordant by simone scuderi, Andrew Vickers et al Read the full article here: buff.ly/4fS0sv9 #UroSoMe #MedTwitter #EditorsChoice

Tobias Nordström delivered the EAU lecture at #SUO24, offering insights into PCa screening using biomarkers and MRI from a European perspective. He concluded that: 🚩 Risk prediction tools shift the benefit/harm balance of PCa early detection. 🚩 Biomarker-based tests

#ProstateCancer screening with biomarkers and MRI–a European perspective. Presentation by Tobias Nordström Karolinska Institutet. #SUO24 written coverage by Julian Chavarriaga University of Toronto > bit.ly/3OH6HFR

Are we missing aggressive cancer with PSA screening alone? Biochemical recurrence after radical prostatectomy: Evidence from the #STHLM3 trial. Presentation by Tobias Nordström Karolinska Institutet. #SUO24 written coverage by Zach Klaassen Georgia Cancer Center > bit.ly/3Vsa47y